Gianluca Pirozzi

SVP, Head of Development, Regulatory and Safety

Gianluca Pirozzi is Senior Vice President, Head of Development and Safety of Alexion, AstraZeneca Rare Disease.

Gianluca Pirozzi

About Gianluca

Gianluca joined Alexion in October 2019 and currently leads the company’s integrated Development, Regulatory and Safety organization. Previously, he served in various roles at Sanofi Genzyme, including Head of Development for Rare Diseases and Gene Therapy. He has served on the Board of Directors of Imbria Pharmaceuticals for two years, and is currently Board Member of Timber Pharmaceuticals, as well as scientific advisor for the Smith-Magenis Syndrome Research Foundation.

Gianluca holds an MD degree from University Campus Bio-Medico and a PhD in Immunology from Sapienza University, both in Rome, Italy, and completed a Post Doctoral Research Fellowship in Immunology at the Pasteur Institute in Paris, France.


Evie, diagnosed with HPP at 2 weeks old, riding a toy car
Her story gives other parents with special needs kids hope that they can be okay, and things can be good.”